Eversept Partners »

Proqr Thrapeutics N V shs euro shares owned by Eversept Partners

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9M 1.0M 1.86

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Encompass Health Corp (EHC)
Ensign (ENSG)
Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Natera (NTRA)
Travere Therapeutics (TVTX)
Caretrust Reit (CTRE)
Hca Holdings (HCA)
Vaxcyte (PCVX)

View all positions for Eversept Partners

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Standard Life Aberdeen
Affinity Asset Advisors
Privium Fund Management B.V.
Ikarian Capital
Woodline Partners
Heights Capital Management
Sphera Funds Management
Kynam Capital Management
DAFNA Capital Management
Squadron Capital Management
683 Capital Management
Morgan Stanley
Citadel Advisors
Platinum Investment Mangement

View all funds holding Proqr Thrapeutics N V shs euro